Drug General Information (ID: DDIB6FZMHV)
  Drug Name Ozanimod Drug Info Macimorelin Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Selective Immunosuppressants Growth Hormones
  Structure

 Mechanism of Ozanimod-Macimorelin Interaction (Severity Level: Major)
     Increased risk of ventricular arrhythmias Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ozanimod Macimorelin
      Mechanism 1 Bradycardia Prolong QT interval
      Key Mechanism Factor 1
Factor Name Ventricular arrhythmias
Factor Description Ventricular arrhythmias are abnormal heart rhythms that cause your heart's lower chambers to pump blood instead of pumping it. This can limit or stop your heart from supplying blood to your body. While some of these arrhythmias are harmless and do not cause symptoms, others can have serious, even fatal, effects on your body.
      Mechanism Description
  • Increased risk of ventricular arrhythmias by the combination of Ozanimod and Macimorelin 
      Mechanism 2 Delay atrioventricular conduction Prolong QT interval
      Key Mechanism Factor 2
Factor Name Ventricular arrhythmias
Factor Description Ventricular arrhythmias are abnormal heart rhythms that cause your heart's lower chambers to pump blood instead of pumping it. This can limit or stop your heart from supplying blood to your body. While some of these arrhythmias are harmless and do not cause symptoms, others can have serious, even fatal, effects on your body.
      Mechanism Description
  • Increased risk of ventricular arrhythmias by the combination of Ozanimod and Macimorelin 

Recommended Action
      Management Ozanimod has not been studied in patients receiving drugs that can prolong the QT interval. Because bradycardia and AV block are recognized risk factors for QT prolongation and torsade de pointes arrhythmia, treatment with ozanimod should generally not be initiated in patients who are concurrently treated with QT prolonging drugs with known arrhythmogenic properties.

References
1 Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.